Interview with Marko Dolzan, President, Polfa Lodz
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
Address: ul. Drewnowska 43/55, 91-002 Lodz
Tel: +48 42 654 00 70
Web: http://www.polfa-lodz.com/
For 75 years, we have been specialising in producing top quality medicinal products, dietary supplements and cosmetics. Thanks to the trust of physicians and pharmacists, our products can be found in every Polish home.
Our strongest desire is to perfect our preparations and to make efforts to increase their safety and efficacy. We are constantly striving to maintain the highest production standards – our production processes comply with GMP, HACCP and ISO standards.
In order to maintain continuous development, we merged with SENSILAB Sp. z o.o. in 2008.
We are one of the leading drugs and dietary supplements manufacturers in Poland. Every year over 5,000,000 packets of our products are shipped to our customers. We offer over 50 different preparations. We are a leading manufacturer of calcium preparations based on the most easily absorbable form of calcium.
We are a pharmaceutical manufacturer which – apart from producing its own preparations – also provides contracted production services. Depending on the demand, our R&D department can develop products to be manufactured under a customer’s brand name. Owing to our modern and highly efficient equipment, we can fulfil your orders promptly. We take production services for our partners very seriously. We treat every enquiry on an individual basis, which results in the comprehensive service that our company can offer.
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
Poland has an important manufacturing role for the CEE region and this is where Mylan has settled Agila, a state-of-the-art, high quality injectables manufacturing platform. Mylan has great ambitions in…
GSK Poland’s General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as the need to implement leaner manufacturing processes to become more…
GSK Poland’s General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as the need to implement leaner manufacturing processes to become more…
GSK Poland’s General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as the need to implement leaner manufacturing processes to become more…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their efforts in finally raising Poland’s footprint in R&D. He…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their efforts in finally raising Poland’s footprint in R&D. He…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their efforts in finally raising Poland’s footprint in R&D. He…
Sanofi’s General Manager in Poland, Marynika Woroszylska-Sapieha, shares two very important concepts that showcase the situation in Poland, stating that: “The biggest obstacle to innovation in Poland is the threshold…
“Average pharmaceutical company expenditures on R&D are in the range of 13 to 15 percent of revenues: much higher than the global average, and much higher than other Polish industrial…
“The swelling influence of wholesalers in the market frightens me.” With three wholesalers in Poland holding 80 percent of the market and establishing their own brands in a changing environment,…
“Instead of creating a state pharmaceutical duopoly, we have created an environment where the pharma industry can introduce new products and market them enthusiastically. This creates a market where pharmaceutical…
Persistence is a blessing, explains Glenmark’s Country Manager for Poland, Andrzej Gondek. By adapting a new product strategy to increase their OTC portfolio, Glenmark managed to nearly double its sales…
See our Cookie Privacy Policy Here